This indica-dominant cultivar (80/20) presents a strong clinical profile, with 2.0% total terpenes and four terpenes present at significant levels above 0.15% w/w. Notable constituents include Limonene (0.5%), beta-Caryophyllene (0.4%), Myrcene (0.2%), and Linalool (0.2%).

While elevated THC levels often come at the expense of terpene expression, Indica 26% retains a balanced profile with measurable terpene content—meeting Southern Sky’s quality-first production standards. The flower is cultivated in small batches under fully controlled indoor conditions using organic coco and soil mix, then hand-picked and hand-trimmed to preserve trichome and terpene integrity.

Based on anecdotal reports, patients describe a strong but mentally uplifting onset that supports sleep initiation without excessive heaviness or cognitive dulling. It is most commonly prescribed for evening and nighttime use in the management of sleep disorders, chronic pain, and PTSD. A subset of experienced patients (primarily those on high-dose THC regimens) have also reported functional daytime use at lower doses for pain and anxiety control.

Given the strength of effect, lower initial vaporisation temperatures and conservative titration are advised when initiating therapy.